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DETERMINATION OF HUMAN CYTOMEGALOVIRUS GENETIC DIVERSITY IN DIFFERENT PATIENT
POPULATIONS IN COSTA RICA
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SUMMARY
Seroprevalence of HCMV in Costa Rica is greater than 95% in adults; primary infections occur early in life and is the most
frequent congenital infection in newborns. The objectives of this study were to determine the genetic variability and genotypes of
HCMV gB gene in Costa Rica. Samples were collected from alcoholics, pregnant women, blood donors, AIDS patients, hematology-
oncology (HO) children and HCMV isolates from neonates with cytomegalic inclusion disease. A semi-nested PCR system was used
to obtain a product of 293-296 bp of the gB gene to be analyzed by Single Stranded Conformational Polymorphism (SSCP) and
sequencing to determine the genetic polymorphic pattern and genotypes, respectively. AIDS patients showed the highest polymorphic
diversity with 14 different patterns while fifty-six percent of HO children samples showed the same polymorphic pattern, suggesting
in this group a possible nosocomial infection. In neonates three genotypes (gB1, gB2 and gB3), were determined while AIDS patients
and blood donors only showed one (gB2). Of all samples analyzed only genotypes gB1, 2 and 3 were determined, genotype gB2 was
the most frequent (73%) and mixed infections were not detected. The results of the study indicate that SSCP could be an important
tool to detect HCMV intra-hospital infections and suggests a need to include additional study populations to better determine the
genotype diversity and prevalence.
KEYWORDS: Human cytomegalovirus; Glycoprotein B; Polymerase chain reaction; Single stranded conformation polymorphism;
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INTRODUCTION
Human Cytomegalovirus (HCMV) infection is generally
asymptomatic in the immunocompetent individual although the virus
persists in the host for life. However, severe infections with different
clinical manifestations are common in immunocompromised patients
with AIDS or chronic diseases and transplant recipients19. In these cases
both primary and recurrent infections can induce severe illness,
representing a major cause of morbidity and mortality with prolonged
hospitalization and high costs6,26.
HCMV glycoprotein B (gB) gene is considered to be a
multifunctional envelope component responsible for virion entry, cell to
cell spread, syncytium formation18 and is the major target for neutralizing
antibodies4,5. Based on sequence variation of the gB gene, HCMV strains
can be classified into four gB genotypes5 and recently, two new genotypes
(gB6 and gB7) have been reported by TRINCADO et al.27. Genotype
variation has been associated with cell tropism, viral pathogenesis and
severity of disease. Several reports have suggested an association of
different gB genotypes with pathogenicity6,13,20,24,26,28,29.
A follow-up study carried out in Costa Rica of 131 mothers and
their newborn babies from birth to six years of age determined that 46%
of the children seroconverted (IgM) during the first three months of
life30. Another study12 demonstrated that HCMV was the most common
cause of congenital disease, and since seroprevalence in Costa Rica is
higher than 95% in adults, it is most likely that this infection is caused
by reactivation and/or reinfection of the virus in the mother during
pregnancy. Although cytomegalic inclusion disease is more likely in a
seronegative pregnant woman who has a primary HCMV infection,
HCMV congenital disease can also be found in infants born to women
with recurrent disease as described by several authors3,17,23,25.
To further understand the diversity of HCMV and possible infectious
routes, the SSCP has shown to be a valuable tool, since only one base
pair (bp) change can affect the DNA Single stranded conformation and
therefore its mobility in aclylamide electrophoresis; which reveals the
different patterns8,9,10.
Since infection and reactivation of HCMV is very common in Costa
Rica, the objectives of this study were to determine the genetic variability
and genotypes of the virus circulating in the country using different
study populations.
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MATERIALS AND METHODS
Study population: Samples available from different populations
for HCMV prevalence studies were used, as follows: 41 Hematology/
oncology (HO) children, 30 AIDS patients, 30 alcoholics, 30 blood
donors and 30 pregnant women were collected from 1998 to 2000 by
the International Center for Medical Research and Training (ICMRT)
and kept at -70 °C. Sixteen HCMV isolates from neonates with congenital
infection recovered in 1984 and control strains of genotype gB1 (Towne
strain), gB2 (AD-169 strain) and gB3 (isolate from a clinical sample)
were also tested. The neonate samples were kept frozen at the Virology
Laboratory at the Faculty of Microbiology, University of Costa Rica
(UCR) and the control samples were donated by Dr. Mia Britting from
the Swedish Institute for Infection and Disease Control, Solna, Sweden.
All study samples were assayed by nested PCR and this product was
further analyzed by SSCP to determine the genetic diversity. Forty-five
samples were selected for the genotype determination representing 23
different polymorphic SSCP patterns (Table 3).
HCMV-DNA extraction: HCMV-DNA was extracted from plasma
by the Qiamp Blood kit (Qiagen, Chatsworth, CA) according to
manufacture recommendations. DNA samples were re-suspended in 200
µl of water.
Amplification of HCMV-DNA: Polymerase Chain Reaction (PCR)
was used to amplify a region of high sequence variability in the gB gene
of HCMV as described by AQUINO & FIGUEIREDO1 with minor
modifications. The reaction mixture had a total volume of 50 µl,
containing 10 µl of DNA sample, 5 µl of PCR 10x buffer, 2.5 mM of
MgCl2, 200 uM each of the dNTPs and 1.6 pM/µl of primers gB1319
(5’TGGAACTGGAACGTTTGGC3’) and gB1676
(5’TGACGCTGGTTTGGTTGATG3’)26 and 2.5 U of Taq DNA
polymerase (Promega). Amplification of DNA was performed in a
thermocycler (Perkin Elmer 9600) with a hot start of 94 °C for 3 minutes,
then 10 cycles of 94 °C for 30 sec, 60 °C for 59 sec, followed by 30
cycles of 94 °C for 30 sec, 55 °C for 45 sec, 72 °C for 59 sec and a final
extension of 72 °C for 3 min. The amplified products of 357 bp were
visualized by electrophoresis in a 2% agarose gel stained with ethidium
bromide.
A semi-nested PCR was performed in all samples to obtain an
amplified product of 293-296 bp. The reaction mixture contained 1 µl of
the first round amplification product using the same concentrations of
reagents as described above; but in a final volume of 40 µl. Primers used
were 2.1 pM/µl of the gB1319 and 2.25 pM/µl of the gB 1604 primer
(5’GAAACGCGCGGCAATCGG3’). Amplification was carried out with
25 cycles at 94 ºC for 30 sec, 55 ºC for 45 sec, 72 ºC for 60 sec, and a
final extension of 72 ºC for 3 min.
Single Strain Conformation Polymorphism (SSCP): SSCP was
performed according to TRINCADO et al.27. The principle of SSCP is a
change in the electrophoretic mobility of the PCR product if there is a bp
change that affects its secondary structure. This can be visualized by
electrophoresis of a denaturalized PCR product in a polyacrylamide with
the appearance of different polymorphic patterns related to the genetic
diversity of each sample8,14. Five µl of the double-stranded semi-nested
PCR product was added to 5 µl formamide buffer (formamide 100%,
bromophenol blue 0.02%, xylene cyanol 0.02% and EDTA 10 mM). DNA
was denatured at 94 ºC for 10 min, then cooled rapidly on ice; denatured
samples were analyzed by electrophoresis on a 7% polyacrylamide gel
(BIO-RAD) at 5 watts for 17 hours at room temperature using a vertical
water-jacketed electrophoresis system (Life Technologies, Air Cooled
System, and S2001). DNA was visualized by silver staining.
HCMV-DNA sequencing: Products of the semi-nested PCR were
purified using the Wizard PCR Preps DNA purification Systems kit
(Promega) and sequenced by the Big Dye Terminator kit (Applied
Biosystems) in a 5% acrylamide gel automatic sequencer (ABI model
373, Applied Biosystems).
The nucleotide sequences were edited by the BIOEDIT programme
(www.mbio.ncsu.edu/BioEdit/bioedit.html) and aligned using the NCBI
(National Center of Biotechnology Information) sequence database.
RESULTS
In PCR 1 a band of 357 bp was visualized and in the semi-nested
PCR a band between 293-296 bp was seen (Fig. 1).
A total of 53 polymorphic patterns were established in the 180 analyzed
samples (Table 1). The group of AIDS patients presented the major genetic
diversity with a total of 14 different patterns followed by the group of
pregnant women with 10, HO children with 8, alcoholics with 7, blood
donors with 6 and HCMV isolates from neonates with 5. Control samples
for gB genotypes showed a different polymorphic pattern for each one.
Figure 2 illustrates the results of the HO children, which showed a
repetitive polymorphic pattern in 17 of the 30 analyzed samples
characterized by the presence of two strong bands at the same positions
in the gel. In these samples also weaker bands were observed that varied
in intensity with some not being visible. These samples were classified
under the same pattern, designed as 1A (Fig. 2). To confirm that this
result was not due to contamination during PCR amplification or to the
separation of the SSCP in the gel, the samples were re-analyzed, initiating
with the extraction of DNA from the original sample. Furthermore, 14
additional samples were included from HO children (Costa Rica) and 5
samples from leukemia children from Nicaragua. The repeated samples
all showed the same pattern A1 as well as 5 of the 14 additional samples
from the HO children and 2 of the 5 from Nicaragua.
Fig. 1 - Electrophoresis in agarose gel of HCMV gB gene of PCR I products (A) (357 bp)
and B PCR II (295-296 bp). Samples 1-4 are HCMV neonate isolations, NC: negative control,
PC: positive control (HCMV, AD 169 strain), WM: weight marker.
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Figure 3 illustrates the diversity of the polymorphic patterns of AIDS
patients (bands I and II) and blood donors (III and IV) with 14 and 6
different patterns, respectively.
Of the 45 sequenced samples 37 were successfully genotyped and
its distribution within the study groups is shown in Table 2. Of the
remaining 8 samples, the genotype could not be determined since
sequenced products were not suitable for this procedure.
Of the six analyzed study groups, neonates were the only group that
showed HCMV genotypes gB1, gB2 and gB3. Pregnant women showed
genotypes gB1 and gB2; HO children and alcoholics showed genotypes
gB2 and gB3, while AIDS patients and blood donors only showed genotype
gB2. However, great difference between these two last groups was detected
regarding frequency of polymorphic patterns with the presence of 14 and
6 patterns, respectively (Fig. 3). The three control sample patterns
corresponded to gB1 (Towne strain) gB2 (strain AD169) and gB3 (Table
2). In alcoholics and neonate isolates, two samples with identical
polymorphic patterns were found to have different genotypes (Table 3).
The distribution of genotypes in the 37 samples were as follows: 27
samples with gB2 (73%), 6 samples with gB1 (16%), 4 samples with
gB3 (11%) and none of these samples had mixed infection. Overall
genotype gB2 was the most frequent (73%) and had the greatest genetic
variability, followed by genotype gB3 and genotype gB1 (Table 3).
DISCUSSION
A semi-nested PCR method was applied to obtain the largest number
of positive samples, since this procedure increase both sensitivity and
specificity. SSCP analysis was used to characterize genetic variations
among the study populations9,15 because this method has shown to be
both sensitive and simple. A change in nucleotide can easily be detected
Table 1
Distribution of techniques used to determine HCMV diversity in different study groups
Study group PCR and SSCP *Letters **Pattern No. Sequenced
HO Children 41 A 1-8 8
AIDS patients 30 B 1-14 7
Alcoholics 30 C 1-7 6
Donors 30 D 1-6 8
Pregnant women 30 E 1-10 6
HCMV isolations 16 F 1-5 7
Reference strains 3 R 1-3 3
Total 180 53 45
*Identification of each study group; **Total polymorphic patterns obtained from each study group
Fig. 3 - SSCP polymorphic patterns of AIDS patients (Group B) and Blood Donors (Group
D), illustrated by the acrylamide electrophoresis bands (I and III) and the schematic presentation
of each pattern (II and IV), respectively.
Fig. 2 - SSCP polymorphic patterns of Hematology/Oncology children (Group A), illustrated
by the acrylamide electrophoresis bands (I) and the schematic presentation of each pattern (II).
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by SSCP, if this alters the secondary structure of the molecule. Therefore,
SSCP has the advantage compared to other techniques such as restriction
fragment polymorphism (RFP) that it is able to detect variations
throughout the amplified product16. Its sensitivity depends mainly on
the size of the DNA fragment11 and is decreased when the size is larger
than 530 pb7. The SSCP fragments in this study were 293-296 bp and 53
different polymorphic patterns were detected in 180 samples.
SSCP has been used for other pathogens (HBV and HCV), showing
that from donor to recipient and mother to neonate the SSCP pattern
was conserved as well as in patients affected by nosocomial outbreaks
in oncology and hemodyalisis units9,10,11.
In 41 samples analyzed from the HO children using SSCP 24 showed
the same polymorphic pattern A1. The hospitalization period among
children with patterns different from A1 were relatively short (< 40 days).
However, in children with pattern A1, although information regarding
hospitalization was incomplete, there was a tendency for it to be over
longer periods. Therefore, we speculate that the high frequency of one
pattern could be related to nosocomial infections, which is further
supported by the fact that the same genotype was established in all
samples with pattern A1 (gB2).
The group of AIDS patients had the major amount of polymorphic
patterns with one genotype (gB2). This could be related to differences
in active replication of HCMV in each of these groups, considering that
AIDS patients frequently show pathologies related to HCMV active
infection and reactivation/reinfection of immunocompromised patients
has been well documented19. The AIDS patients results were similar to
those reported by BALE et al.2, RASMUSSEN et al.21, ROSEN et al.22,
WOO et al.29 in showing the presence of genotype gB2. On the contrary,
blood donors showed few polymorphic patterns probably related to a
latent disease state, also with only the presence of genotype gB2.
Two situations were observed where different genotypes had the
same polymorphic patterns, showing that the difference of bp’s related
to genotypes did not cause structural changes.
None of the samples had mixed HCMV infections, different from
the results reported by AQUINO & FIGUEIREDO1. They found different
genotypes according to the site of infection and specimen, which suggests
a cellular tropism among different genotypes. Therefore, the use of only
plasma samples as in this study do not allow us to make final conclusions
about the mixed infections in these populations.
In conclusion SSCP method showed a high sensitivity for detection
of genetic variations in the samples analyzed (53/180), but maybe even
more important was the capacity to identify equal polymorphic patterns
that relates to the same origin and therefore could be an indication of
nosocomial infection. The results obtained show the need to carry out
further studies focusing on a possible nosocomial infection at the National
Children’s Hospital, to determine if strain A1 is of dominant circulation
within the hospital and also to evaluate its possible resistance to the
antiviral drugs currently in use.
The data show the predominance of HCMV genotype gB2 in Costa
Rica among the study groups, with its limitations regarding the number
of total individuals analyzed and the type of samples used (only plasma).
In the future this study should be amplified including a more diverse
study population and collection of different specimens from each
participant with an approach of longitudinal studies.
RESUMEN
Determinación de la diversidad genética del citomegalovirus
humano en diferentes poblaciones de pacientes en Costa Rica
La seroprevalencia de citomegalovirus es mayor del 95% en la
población adulta de Costa Rica; la infección primaria ocurre muy
temprano en la vida y es la infección congénita más frecuente en recién
nacidos. El objetivo de este trabajo fue determinar la variabilidad genética
y los genotipos del gene gB del citomegalovirus humano. Se recolectaron
muestras de sangre de mujeres embarazadas, alcohólicos, pacientes con
Table 3
HCMV polymorphic patterns according to genotypes in the different study
groups
Study population Polymorphic patterns Genotypes
HO children A1 gB2
A5 gB3
AIDS patients B1, B3, B5 gB2
Alcoholics C1, C2, * C6 gB2
* C6 gB3
Donors D1, D2, D3
D4, D5, D6 gB2
Pregnant women E3 gB1
E1, E2 gB2
HCMV isolations * F2, F4 gB1
F1, * F2, gB2
F3 gB3
Reference strains R4 gB1
R5 gB2
R6 gB3
* The same letters and numbers identify equal polymorphic patterns
Table 2
Distribution of HCMV gB genotypes within the study groups
Genotypes
Study group *Analyzed samples gB1 gB2 gB3 gB4
HO Children 8 4 1
AIDS patients 7 4
Alcoholics 6 4 1
Donors 8 7
Pregnant women 6 2 4
HCMV isolations 7 3 3 1
Reference strains 3 1 1 1
Total *45 6 27 4
* Of 45 samples sequenced, 37 could be genotyped and 8 were not able to be
edited
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SIDA, niños con trastornos hemato-oncológicos, donadores de sangre y
se incluyeron aislamientos de citomegalovirus de neonatos con
enfermedad congénita. Se utilizó un sistema de PCR semi-anidado para
obtener una banda de 293-296 pares de bases, la cual fue analizada por
la técnica de Polimorfismo conformacional de banda simple (PCBS) y
secuenciada para determinar los patrones genéticos polimórficos y los
genotipos, respectivamente. La mayor diversidad polimórfica se encontró
en los pacientes con SIDA con 14 patrones diferentes mientras que en
los niños con trastornos hemato-oncológicos se demostró el mismo patrón
en el 56% de los casos, sugiriendo una posible infección nosocomial en
este grupo. En los neonatos se encontraron tres genotipos (gB1, gB2,
gB3) mientras que en los pacientes con SIDA y en los donadores de
sangre solo se demostró el gB2. En las muestras analizadas se
determinaron los genotipos gB1, gB2 y gB3 y el gB2 se determinó en el
73% de los casos, no se detectaron infecciones mixtas. Los resultados
de este trabajo indican que la técnica del PCBS puede ser una herramienta
importante para detectar el citomegalovirus humano en infecciones
intrahospitalarias y se sugiere la importancia de incluir poblaciones de
estudio adicionales para determinar mejor la diversidad genética y su
prevalencia.
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